|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/48 | |
| A61K 9/107 | |||
| A61K 9/14 | |||
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61K 9/50 | |||
| A61K 31/505 |
| (11) | Number of the document | 1567134 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03789453.2 |
| Date of filing the European patent application | 2003-11-25 | |
| (97) | Date of publication of the European application | 2005-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2003/050890 |
| Date | 2003-11-25 |
| (87) | Number | WO 2004/050058 |
| Date | 2004-06-17 |
| (30) | Number | Date | Country code |
| PCT/EP02/13558 | 2002-11-29 | WO |
| (72) |
VANDECRUYS, Roger, Petrus, Gerebern, BE
PEETERS, Jozef, BE
BREWSTER, Marcus, Eli, BE
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | Pharmaceutical compositions comprising a basic drug compound, vitamin E TPGS and a physiologically tolerable water-soluble acid |
| Pharmaceutical compositions comprising a basic drug compound, vitamin E TPGS and a physiologically tolerable water-soluble acid |